Ticker
BCABCompany Name
BIOATLA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Cash and Equivalents | Total Debt | Enterprise Value | Market Capitalization |
---|---|---|---|---|
6/30/2025 | $ 18.21M | $ 6.04M | $ 10.15M | $ 22.31M |
3/31/2025 | $ 32.36M | $ 554K | $ -4.06M | $ 27.75M |
12/31/2024 | $ 49.05M | $ 836K | $ -26.43M | $ 21.78M |
9/30/2024 | $ 56.52M | $ 1.25M | $ 52.06M | $ 107.33M |
6/30/2024 | $ 61.66M | $ 1.66M | $ 11.05M | $ 71.05M |
3/31/2024 | $ 80.63M | $ 1.92M | $ 46.88M | $ 125.58M |
12/31/2023 | $ 111.47M | $ 2.46M | $ 35.76M | $ 144.77M |
9/30/2023 | $ 141.28M | $ 2.85M | $ -54.07M | $ 84.37M |
6/30/2023 | $ 168.69M | $ 3.23M | $ -27.79M | $ 137.67M |
3/31/2023 | $ 192.69M | $ 3.61M | $ -36.07M | $ 153.01M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Market Cap + Debt - CashnEq
(=) EV
EV for BIOATLA INC is calculated as follows: Market Cap [ $ 0 ] + Debt [ $ 682K ] - CashnEq [ $ 56.76M ]
(=) EV [ $ 0 ]
Minimum
Mar 31, 2022
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 3.32K |
---|---|
min | $ -1.69B |
max | $ 6.83B |
average | $ 1.25B |
median | $ 439.42M |
std | $ 1.67B |